Holen Sie sich die Stockscreener-App
2.38
10.19%
-0.27
Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.0653 | 0.1008 | - | 0.1027 |
Operating Expenses
|
8.09%
23.08
|
25.12 | 33.30 | 31.48 | 27.50 |
| Benefits Costs and Expenses |
-
|
- | - | - | 25.11 |
| Costs And Expenses |
8.09%
23.08
|
25.12 | 33.30 | 31.48 | 25.11 |
| Operating Income/Loss |
7.85%
-23.08
|
-25.05 | -33.20 | -31.48 | -27.39 |
| Income/Loss From Continuing Operations Before Tax |
19.42%
-23.52
|
-19.69 | 0.1008 | -30.47 | -25.00 |
| Income/Loss From Continuing Operations After Tax |
19.42%
-23.52
|
-19.69 | -32.24 | -30.47 | -24.97 |
|
Net Income/Loss
|
19.42%
-23.52
|
-19.69 | -32.24 | -30.47 | -25.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.56%
38.83
|
38.61 | 27.20 | 23.29 | -241.67 |
| Diluted Average Shares |
0.56%
38.83
|
38.61 | 27.20 | 23.29 | -241.67 |
| Basic Earnings Per Share |
19.61%
-0.61
|
-0.51 | -1.19 | -1.31 | -5.67 |
| Diluted Earnings Per Share |
19.61%
-0.61
|
-0.51 | -1.19 | -1.31 | -5.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):